Physician profile
Jeremiah Murphy
NPI 1295750222
$2,567.30
in general payments reported to CMS, 2019-2025
30 companies · $558 in 2025
The $558 reported for 2025 was more than what 81% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $595 · 2020: $142 · 2021: $197 · 2022: $170 · 2023: $336 · 2024: $569 · 2025: $558.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,440 · Education: $24.02.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,439.59 |
| Education | $24.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $410.14 | 2019-2023 | Myrbetriq |
| 180 Medical, INC. | $282.81 | 2019-2025 | Gentlecath, Gentlecath Glide, Cure Ultra Catheter |
| Janssen Biotech, INC. | $271.70 | 2019-2025 | Erleada, Akeega |
| Urogen Pharma, INC. | $266.50 | 2024-2025 | |
| Pfizer INC. | $190.37 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $178.36 | 2023-2025 | Gemtesa |
| Abbvie INC. | $135.10 | 2019-2025 | |
| Endo USA, INC. | $120.44 | 2024-2025 | Xiaflex |
| Tolmar, INC. | $73.90 | 2024-2025 | Eligard |
| Boston Scientific Corporation | $66.71 | 2019-2023 | Rezum Generator |
| Coloplast Corp | $53.17 | 2020-2021 | |
| Travere Therapeutics, INC. | $52.99 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $50.07 | 2024 | Keytruda |
| Endo Pharmaceuticals INC. | $47.98 | 2019-2024 | Xiaflex |
| Axonics, INC. | $47.42 | 2023-2024 | Axonics, Bulkamid |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $47.15 | 2022-2025 | |
| Conmed Corporation | $42.49 | 2022-2023 | Airseal |
| Vertex Pharmaceuticals Incorporated | $41.37 | 2025 | |
| Urovant Sciences INC | $28.05 | 2022 | |
| Dendreon Pharmaceuticals LLC | $19.26 | 2019 | |
| Medtronic USA, INC. | $17.64 | 2019 | |
| Sun Pharmaceutical Industries INC. | $16.02 | 2019 | |
| Immunitybio, INC. | $15.18 | 2024 | |
| Olympus America INC. | $14.88 | 2023 | Itind System |
| Karl Storz Endoscopy-America | $14.42 | 2019 | |
| Rochester Medical Corporation | $13.72 | 2021 | |
| Ambu INC. | $13.43 | 2021 | |
| Teleflex LLC | $13.07 | 2024 | |
| Janssen Pharmaceuticals, INC | $11.60 | 2019 | |
| Convatec INC. | $11.36 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeremiah Murphy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.